Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 406

1.

Acute stroke rehabilitation for gait training with cyborg type robot Hybrid Assistive Limb: A pilot study.

Yokota C, Yamamoto Y, Kamada M, Nakai M, Nishimura K, Ando D, Sato T, Koga M, Ihara M, Toyoda K, Fujimoto Y, Odani H, Minematsu K, Nakajima T.

J Neurol Sci. 2019 Jul 10;404:11-15. doi: 10.1016/j.jns.2019.07.012. [Epub ahead of print]

PMID:
31323516
2.

Japanese Versus Non-Japanese Patients with Transient Ischemic Attack or Minor Stroke: Subanalysis of TIA registry.org.

Uchiyama S, Hoshino T, Sissani L, Linsay MT, Kamiyama K, Nakase T, Kitagawa K, Minematsu K, Todo K, Okada Y, Nakagawara J, Nagata K, Yamagami H, Yamaguchi T, Amarenco P; TIAregistry.org Investigators.

J Stroke Cerebrovasc Dis. 2019 Jun 6. pii: S1052-3057(19)30225-3. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.005. [Epub ahead of print]

3.

Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.

Toyoda K, Uchiyama S, Yamaguchi T, Easton JD, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K; CSPS.com Trial Investigators.

Lancet Neurol. 2019 Jun;18(6):539-548. doi: 10.1016/S1474-4422(19)30148-6.

PMID:
31122494
4.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.

Easton JD, Denison H, Evans SR, Knutsson M, Amarenco P, Albers GW, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KL, Johnston SC; SOCRATES Steering Committee and Investigators.

Int J Stroke. 2019 May 15:1747493019851282. doi: 10.1177/1747493019851282. [Epub ahead of print]

PMID:
31092152
5.

Baseline Carotid Intima-Media Thickness and Stroke Recurrence During Secondary Prevention With Pravastatin.

Wada S, Koga M, Minematsu K, Toyoda K, Suzuki R, Kagimura T, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Matsumoto M.

Stroke. 2019 Jun;50(6):1586-1589. doi: 10.1161/STROKEAHA.119.024968. Epub 2019 Apr 30.

PMID:
31035902
6.

Small vessel occlusion is a high-risk etiology for early recurrent stroke after transient ischemic attack.

Ohara T, Uehara T, Sato S, Hayakawa M, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; PROMISE-TIA Study Investigators.

Int J Stroke. 2019 Mar 27:1747493019840931. doi: 10.1177/1747493019840931. [Epub ahead of print]

PMID:
30917776
7.

Effectiveness of a new multi-component smoking cessation service package for patients with hypertension and diabetes in northern Thailand: a randomized controlled trial (ESCAPE study).

Aung MN, Yuasa M, Moolphate S, Lorga T, Yokokawa H, Fukuda H, Kitajima T, Tanimura S, Hiratsuka Y, Ono K, Thinuan P, Minematsu K, Deerojanawong J, Suya Y, Marui E.

Subst Abuse Treat Prev Policy. 2019 Feb 22;14(1):10. doi: 10.1186/s13011-019-0197-2.

8.

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).

Ogawa A, Toyoda K, Kitagawa K, Kitazono T, Nagao T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y; PRASTRO-I Study Group.

Lancet Neurol. 2019 Mar;18(3):238-247. doi: 10.1016/S1474-4422(18)30449-6. Epub 2019 Feb 12.

PMID:
30784555
9.

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.

Molina CA, Johnston SC, Ladenvall P, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Knutsson M, Minematsu K, Röther J, Wang Y, Wong KSL; SOCRATES Steering Committee and Investigators.

Stroke. 2019 Mar;50(3):675-682. doi: 10.1161/STROKEAHA.118.022675. Erratum in: Stroke. 2019 Apr;50(4):e118.

PMID:
30776996
10.

Rivaroxaban administration after acute ischemic stroke: The RELAXED study.

Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T, Yamagami H, Nagao T, Yoshimura S, Uchiyama S; RELAXED study group.

PLoS One. 2019 Feb 13;14(2):e0212354. doi: 10.1371/journal.pone.0212354. eCollection 2019.

11.

Real-world outcomes of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Takeichi M, Ohashi Y, Okayama Y, Sunaya T, Yamanaka S.

J Cardiol. 2019 Jul;74(1):60-66. doi: 10.1016/j.jjcc.2019.01.001. Epub 2019 Feb 8.

PMID:
30745002
12.

Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIA.

Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS collaborators.

J Atheroscler Thromb. 2019 May 1;26(5):432-441. doi: 10.5551/jat.45989. Epub 2018 Oct 15.

13.

Significance of Nonfocal Symptoms in Patients With Transient Ischemic Attack.

Ishihara T, Sato S, Uehara T, Ohara T, Hayakawa M, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; PROMISE-TIA Study Investigators.

Stroke. 2018 Aug;49(8):1893-1898. doi: 10.1161/STROKEAHA.118.022009.

PMID:
30012818
14.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.

Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.

15.

Endovascular Therapy in Ischemic Stroke With Acute Large-Vessel Occlusion: Recovery by Endovascular Salvage for Cerebral Ultra-Acute Embolism Japan Registry 2.

Yoshimura S, Sakai N, Uchida K, Yamagami H, Ezura M, Okada Y, Kitagawa K, Kimura K, Sasaki M, Tanahashi N, Toyoda K, Furui E, Matsumaru Y, Minematsu K, Morimoto T.

J Am Heart Assoc. 2018 Apr 25;7(9). pii: e008796. doi: 10.1161/JAHA.118.008796.

16.

Change in mobility function and its causes in adults with cerebral palsy by Gross Motor Function Classification System level: A cross-sectional questionnaire study.

Himuro N, Mishima R, Seshimo T, Morishima T, Kosaki K, Ibe S, Asagai Y, Minematsu K, Kurita K, Okayasu T, Shimura T, Hoshino K, Suzuki T, Yanagizono T.

NeuroRehabilitation. 2018;42(4):383-390. doi: 10.3233/NRE-172340.

PMID:
29660955
17.

Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Ogawa S, Minematsu K, Ikeda T, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Ohashi Y, Takeichi M, Okayama Y, Yamanaka S, Inuyama L.

J Arrhythm. 2018 Feb 7;34(2):167-175. doi: 10.1002/joa3.12034. eCollection 2018 Apr.

18.

Seasonal Variations in Neurological Severity and Outcomes of Ischemic Stroke - 5-Year Single-Center Observational Study.

Toyoda K, Koga M, Yamagami H, Yokota C, Sato S, Inoue M, Tanaka T, Endo K, Fujinami J, Ihara M, Nagatsuka K, Minematsu K.

Circ J. 2018 Apr 25;82(5):1443-1450. doi: 10.1253/circj.CJ-17-1310. Epub 2018 Mar 31.

19.

Spreading Awareness of Stroke through School-Based Education: A Pooled Analysis of Three Community-Based Studies.

Hino T, Yokota C, Nishimura K, Nakai M, Kato S, Kuwabara K, Takekawa H, Arimizu T, Tomari S, Wada S, Ohnishi H, Toyoda K, Okamura T, Minematsu K.

J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1810-1814. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.008. Epub 2018 Mar 12.

PMID:
29544681
20.

Comparison of Clinical Characteristics among Subtypes of Visual Symptoms in Patients with Transient Ischemic Attack: Analysis of the PROspective Multicenter registry to Identify Subsequent cardiovascular Events after TIA (PROMISE-TIA) Registry.

Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; PROMISE-TIA study Investigators.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1711-1716. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.031. Epub 2018 Mar 8.

PMID:
29525079
21.

Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).

Hosomi N, Kitagawa K, Nagai Y, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS Collaborators.

Stroke. 2018 Apr;49(4):865-871. doi: 10.1161/STROKEAHA.117.018870. Epub 2018 Mar 6.

PMID:
29511130
22.

A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trial.

Nagao T, Toyoda K, Kitagawa K, Kitazono T, Yamagami H, Uchiyama S, Tanahashi N, Matsumoto M, Minematsu K, Nagata I, Nishikawa M, Nanto S, Abe K, Ikeda Y, Ogawa A.

Expert Opin Pharmacother. 2018 Apr;19(6):529-535. doi: 10.1080/14656566.2018.1444029. Epub 2018 Mar 26.

PMID:
29463150
23.

Improving Call-to-Door Time Using School-Based Intervention by Emergency Medical Technicians: The Akashi Project.

Arimizu T, Yokota C, Tomari S, Hino T, Wada S, Ohnishi H, Toyoda K, Minematsu K.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1552-1555. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.006.

PMID:
29402615
24.

Effects of a school-based stroke education program on stroke-related knowledge and behaviour modification-school class based intervention study for elementary school students and parental guardians in a Japanese rural area.

Kato S, Okamura T, Kuwabara K, Takekawa H, Nagao M, Umesawa M, Sugiyama D, Miyamatsu N, Hino T, Wada S, Arimizu T, Takebayashi T, Kobashi G, Hirata K, Yokota C, Minematsu K.

BMJ Open. 2017 Dec 21;7(12):e017632. doi: 10.1136/bmjopen-2017-017632.

25.

Long-Term Effect of Pravastatin on Carotid Intima-Media Complex Thickness: The J-STARS Echo Study (Japan Statin Treatment Against Recurrent Stroke).

Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; J-STARS Investigators.

Stroke. 2018 Jan;49(1):107-113. doi: 10.1161/STROKEAHA.117.018387. Epub 2017 Nov 30.

26.

Factors for C-Kit Expression in Cardiac Outgrowth Cells and Human Heart Tissue.

Matsushita S, Minematsu K, Yamamoto T, Inaba H, Kuwaki K, Shimada A, Yokoyama Y, Amano A.

Int Heart J. 2017 Dec 12;58(6):962-968. doi: 10.1536/ihj.16-559. Epub 2017 Nov 17.

27.

Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.

Osanai T, Houkin K, Uchiyama S, Minematsu K, Taguchi A, Terasaka S.

Int J Stroke. 2018 Jun;13(4):444-448. doi: 10.1177/1747493017743057. Epub 2017 Nov 14.

28.

Factors Associated with Intima-Media Complex Thickness of the Common Carotid Artery in Japanese Noncardioembolic Stroke Patients with Hyperlipidemia: The J-STARS Echo Study.

Wada S, Koga M, Toyoda K, Minematsu K, Yasaka M, Nagai Y, Aoki S, Nezu T, Hosomi N, Kagimura T, Origasa H, Kamiyama K, Suzuki R, Ohtsuki T, Maruyama H, Kitagawa K, Uchiyama S, Matsumoto M; Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study Collaborators.

J Atheroscler Thromb. 2018 Apr 1;25(4):359-373. doi: 10.5551/jat.41533. Epub 2017 Nov 8.

29.

Predictors of Stroke Events in Patients with Transient Ischemic Attack Attributable to Intracranial Stenotic Lesions.

Uehara T, Ohara T, Minematsu K, Nagatsuka K, Toyoda K.

Intern Med. 2018 Feb 1;57(3):295-300. doi: 10.2169/internalmedicine.9447-17. Epub 2017 Nov 1.

30.

Effects of school-based intervention by emergency medical technicians on students and their parents: a community-based prospective study of the Akashi project.

Tomari S, Yokota C, Nishimura K, Hino T, Ohyama S, Arimizu T, Wada S, Ohnishi H, Toyoda K, Minematsu K.

BMJ Open. 2017 Oct 15;7(10):e016780. doi: 10.1136/bmjopen-2017-016780.

31.

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event.

Hosomi N, Nagai Y, Kitagawa K, Nakagawa Y, Aoki S, Nezu T, Kagimura T, Maruyama H, Origasa H, Minematsu K, Uchiyama S, Matsumoto M; J-STARS collaborators.

J Atheroscler Thromb. 2018 Mar 1;25(3):262-268. doi: 10.5551/jat.40196. Epub 2017 Sep 16.

32.

Clinical Characteristics and Outcomes of Intracerebral Hemorrhage in Very Elderly.

Inoue Y, Miyashita F, Minematsu K, Toyoda K.

J Stroke Cerebrovasc Dis. 2018 Jan;27(1):97-102. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.006. Epub 2017 Oct 12.

PMID:
28893575
33.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Sep;48(9):2480-2487. doi: 10.1161/STROKEAHA.117.017217. Epub 2017 Jul 18.

PMID:
28720658
34.

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).

Easton JD, Aunes M, Albers GW, Amarenco P, Bokelund-Singh S, Denison H, Evans SR, Held P, Jahreskog M, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Circulation. 2017 Sep 5;136(10):907-916. doi: 10.1161/CIRCULATIONAHA.117.028566. Epub 2017 Jun 27.

PMID:
28655834
35.

Unclear-onset intracerebral hemorrhage: Clinical characteristics, hematoma features, and outcomes.

Inoue Y, Miyashita F, Koga M, Minematsu K, Toyoda K.

Int J Stroke. 2017 Dec;12(9):961-968. doi: 10.1177/1747493017702664. Epub 2017 Mar 31.

PMID:
28361615
36.

Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS.

Kitagawa K, Hosomi N, Nagai Y, Kagimura T, Ohtsuki T, Origasa H, Minematsu K, Uchiyama S, Nakamura M, Matsumoto M; J-STARS Investigators.

J Atheroscler Thromb. 2017 Oct 1;24(10):1039-1047. doi: 10.5551/jat.39354. Epub 2017 Mar 7.

37.

Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Lancet Neurol. 2017 Apr;16(4):301-310. doi: 10.1016/S1474-4422(17)30038-8. Epub 2017 Feb 23.

PMID:
28238711
38.

Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease.

Hashimoto T, Yokota C, Koshino K, Temma T, Yamazaki M, Iguchi S, Shimomura R, Uehara T, Funatsu N, Hino T, Minematsu K, Iida H, Toyoda K.

Ann Nucl Med. 2017 Apr;31(3):227-234. doi: 10.1007/s12149-017-1152-9. Epub 2017 Feb 20.

PMID:
28220365
39.

Ten-year standardization of lipids and high-sensitivity C-reactive protein in a randomized controlled trial to assess the effects of statins on secondary stroke prevention: Japan Statin Treatment Against Recurrent Stroke.

Nakamura M, Fukukawa T, Kitagawa K, Nagai Y, Hosomi N, Minematsu K, Uchiyama S, Matsumoto M, Miyamoto Y; for J-STARS collaborators.

Ann Clin Biochem. 2018 Jan;55(1):128-135. doi: 10.1177/0004563217693651. Epub 2017 Jul 10.

PMID:
28135841
40.

The Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study: Rationale and Trial Protocol.

Toyoda K, Minematsu K, Yasaka M, Nagai Y, Hosomi N, Origasa H, Kitagawa K, Uchiyama S, Koga M, Matsumoto M; J-STARS Investigators.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):595-599. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.113. Epub 2016 Dec 20.

PMID:
28010953
41.

Risk Factors.

Uehara T, Bang OY, Kim JS, Minematsu K, Sacco R.

Front Neurol Neurosci. 2016;40:47-57. Epub 2016 Dec 2. Review.

PMID:
27960158
42.

Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).

Wang Y, Minematsu K, Wong KS, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Molina CA, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Jan;48(1):167-173. doi: 10.1161/STROKEAHA.116.014891. Epub 2016 Nov 29.

PMID:
27899747
43.

Delivering Knowledge of Stroke to Parents Through Their Children Using a Manga for Stroke Education in Elementary School.

Ishigami A, Yokota C, Nishimura K, Ohyama S, Tomari S, Hino T, Arimizu T, Wada S, Toyoda K, Minematsu K.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):431-437. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.005. Epub 2016 Nov 9.

PMID:
27838177
44.

Incidence, predictors, and etiology of subsequent ischemic stroke within one year after transient ischemic attack.

Uehara T, Minematsu K, Ohara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Uchiyama S, Matsumoto M, Iihara K, Toyoda K; PROMISE-TIA study Investigators.

Int J Stroke. 2017 Jan;12(1):84-89. doi: 10.1177/1747493016669884. Epub 2016 Sep 24.

PMID:
27649736
45.

Differences in Clinical Characteristics between Patients with Transient Ischemic Attack Whose Symptoms Do and Do Not Persist on Arrival.

Tanaka K, Uehara T, Kimura K, Okada Y, Hasegawa Y, Tanahashi N, Suzuki A, Takagi S, Nakagawara J, Arii K, Nagahiro S, Ogasawara K, Nagao T, Uchiyama S, Matsumoto M, Iihara K, Toyoda K, Minematsu K; Japan TIA Research Group, 2009-2011.

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2237-42. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.025. Epub 2016 Jun 3.

PMID:
27266623
46.

Cerebral blood flow and metabolism associated with cerebral microbleeds in small vessel disease.

Hashimoto T, Yokota C, Koshino K, Shimomura R, Hino T, Moriguchi T, Hori Y, Uehara T, Minematsu K, Iida H, Toyoda K.

Ann Nucl Med. 2016 Aug;30(7):494-500. doi: 10.1007/s12149-016-1086-7. Epub 2016 May 31.

PMID:
27246951
47.

Identification of lactate dehydrogenase as a mammalian pyrroloquinoline quinone (PQQ)-binding protein.

Akagawa M, Minematsu K, Shibata T, Kondo T, Ishii T, Uchida K.

Sci Rep. 2016 May 27;6:26723. doi: 10.1038/srep26723.

48.

Ipsilateral hemiparesis in lateral medullary infarction: Clinical investigation of the lesion location on magnetic resonance imaging.

Uemura M, Naritomi H, Uno H, Umesaki A, Miyashita K, Toyoda K, Minematsu K, Nagatsuka K.

J Neurol Sci. 2016 Jun 15;365:40-5. doi: 10.1016/j.jns.2016.04.006. Epub 2016 Apr 10.

PMID:
27206871
49.

Rapid Identification of Type A Aortic Dissection as a Cause of Acute Ischemic Stroke.

Ohara T, Koga M, Tokuda N, Tanaka E, Yokoyama H, Minatoya K, Nagatsuka K, Toyoda K, Minematsu K.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1901-6. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.005. Epub 2016 May 10.

PMID:
27177921
50.

Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.

Uchiyama S, Ishizuka N, Shimada K, Teramoto T, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Minematsu K, Matsumoto M, Ikeda Y; JPPP Study Group.

Stroke. 2016 Jun;47(6):1605-11. doi: 10.1161/STROKEAHA.115.012461. Epub 2016 May 10. Erratum in: Stroke. 2018 Oct;49(10):e307.

PMID:
27165949

Supplemental Content

Loading ...
Support Center